Medibis

Medibis is an Australian medical cannabis company dedicated to improving patient outcomes through the supply of high-quality cannabinoid-based medicines. Founded in 2018, the company focuses on the development and distribution of pharmaceutical-grade CBD and THC formulations, including oils and dried flower products. Medibis operates within the Australian regulatory framework, primarily utilizing the Special Access Scheme to provide treatments for chronic pain, anxiety, and neurological conditions. The company emphasizes a patient-first philosophy, ensuring that its products are both accessible and rigorously tested for safety and efficacy. By collaborating with healthcare professionals and strategic manufacturing partners, Medibis maintains a robust supply chain for the domestic market.